NCT06438965View on ClinicalTrials.gov

MSOT as Non-invasive Biomarker for Diagnosis and Monitoring of Neuromuscular Diseases

RecruitingOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

February 7, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2028

Conditions
Neuromuscular Diseases
Interventions
DEVICE

Multispectral Optoacoustic Tomography (MSOT)

MSOT scans will be obtained from two muscle region to measure hemo/myoglobin, collagen and lipid content/signal and oxygenation in patient with neuromuscular diseases.

Trial Locations (1)

K1H 8L1

RECRUITING

CHEO, Ottawa

All Listed Sponsors
lead

Children's Hospital of Eastern Ontario

OTHER